| Package | smart.who.int.immunizations |
| Type | CodeSystem |
| Id | IMMZ.I |
| FHIR Version | R4 |
| Source | http://smart.who.int/immunizations/https://build.fhir.org/ig/WorldHealthOrganization/smart-immunizations/CodeSystem-IMMZ.I.html |
| URL | http://smart.who.int/immunizations/CodeSystem/IMMZ.I |
| Version | 0.2.0 |
| Status | active |
| Date | 2025-07-02T19:45:20+00:00 |
| Name | IMMZ_I |
| Title | IMMZ.I CodeSystem for Data Elements |
| Authority | who |
| Description | CodeSystem for IMMZ.I Data Elements |
| Content | complete |
| ValueSet | |
| IMMZ.I.DE30 | IMMZ.I.DE30 ValueSet for Disaggregation group |
| IMMZ.I.DE48 | IMMZ.I.DE48 ValueSet for Closed stock discarded type |
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: CodeSystem IMMZ.I
This case-insensitive code system http://smart.who.int/immunizations/CodeSystem/IMMZ.I defines the following codes:
FHIR{
"resourceType": "CodeSystem",
"id": "IMMZ.I",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"url": "http://smart.who.int/immunizations/CodeSystem/IMMZ.I",
"version": "0.2.0",
"name": "IMMZ_I",
"title": "IMMZ.I CodeSystem for Data Elements",
"status": "active",
"experimental": false,
"date": "2025-07-02T19:45:20+00:00",
"publisher": "WHO",
"contact": [
{
"name": "WHO",
"telecom": [
{
"system": "url",
"value": "http://who.int"
}
]
}
],
"description": "CodeSystem for IMMZ.I Data Elements",
"caseSensitive": false,
"content": "complete",
"count": 27,
"concept": [
{
"code": "DE40",
"display": "Number of doses per vial",
"definition": "The number of doses contained within a vial"
},
{
"code": "DE41",
"display": "Initial balance",
"definition": "The initial quantity of vials in stock at the beginning of a specific reporting period"
},
{
"code": "DE42",
"display": "Closing balance",
"definition": "The quantity of vials in stock at the end of a specific reporting period"
},
{
"code": "DE43",
"display": "Administered doses",
"definition": "The quantity of vials that have been administered to clients during a specified time frame"
},
{
"code": "DE44",
"display": "Stock opened",
"definition": "The quantity of vials that were opened during a specific period"
},
{
"code": "DE45",
"display": "Stock received",
"definition": "The quantity of vials that have been received from external sources, such as suppliers, during a specific period"
},
{
"code": "DE46",
"display": "Physical count adjustment",
"definition": "An adjustment made to the stock level to correct discrepancies between the recorded inventory and the actual physical count, which may be necessary owing to errors, theft or other discrepancies"
},
{
"code": "DE47",
"display": "Closed stock discarded",
"definition": "The quantity of vials that were not opened and have been wasted or discarded, owing to expiration or other reasons, during a specific period"
},
{
"code": "DE48",
"display": "Closed stock discarded type",
"definition": "Specific reason for the disposal of vaccine"
},
{
"code": "DE49",
"display": "Broken/damaged",
"definition": "The vaccine is physically damaged or broken, rendering it unsuitable for use"
},
{
"code": "DE50",
"display": "Expired product",
"definition": "The vaccine has reached its expiration date and is no longer safe or effective for use"
},
{
"code": "DE51",
"display": "Cold storage malfunction",
"definition": "There has been a malfunction or failure in the cold storage equipment, which has led to the degradation of the vaccine"
},
{
"code": "DE52",
"display": "Vaccine vial monitor status change",
"definition": "The vaccine vial monitor has indicated a change in status, possibly indicating that the vaccines may no longer be viable"
},
{
"code": "DE53",
"display": "Frozen",
"definition": "The vaccine has been exposed to freezing temperatures, making it unsuitable for use as freezing can affect the integrity and efficacy of certain immunization products"
},
{
"code": "DE18",
"display": "Report subject area",
"definition": "Location (vaccination location or place) for which the data in the report are being represented"
},
{
"code": "DE20",
"display": "Reporting period start date",
"definition": "The start date of the reporting period for which data in the report have been included"
},
{
"code": "DE21",
"display": "Reporting period end date",
"definition": "The end date of the reporting period for which data in the report have been included"
},
{
"code": "DE30",
"display": "Disaggregation group",
"definition": "Indicates the overall strata or disaggregation represented in the report (e.g. by gender, by region, by age group, etc.)"
},
{
"code": "DE31",
"display": "By-Sex",
"definition": "A disaggregation grouped by the indicator population's sex values"
},
{
"code": "DE32",
"display": "By-Administrative Area",
"definition": "A disaggregation grouped by the indicator population's administrative regions/areas"
},
{
"code": "DE33",
"display": "By-Age group",
"definition": "A disaggregation grouped by the indicator population's age groups"
},
{
"code": "DE34",
"display": "By-Dose number",
"definition": "A disaggregation grouped by the indicator population's dose numbers for a specific vaccine"
},
{
"code": "DE35",
"display": "By-Vaccine type",
"definition": "A disaggregation grouped by the indicator population's vaccine types"
},
{
"code": "DE36",
"display": "By-Vaccine manufacturer",
"definition": "A disaggregation grouped by the indicator population's vaccine manufacturers for a specific vaccine"
},
{
"code": "DE37",
"display": "By-Reaction manifestation",
"definition": "A disaggregation grouped by the indicator population's reaction manifestations for a specific vaccine"
},
{
"code": "DE39",
"display": "By-Type of reaction",
"definition": "A disaggregation grouped by the indicator population's type of reaction for a specific vaccine"
},
{
"code": "DE54",
"display": "By-Risk and occupational group",
"definition": "A disaggregation grouped by the indicator population's risk and occupational group"
}
]
}